David Forster
Compliance Officer presso WCG CLINICAL, INC.
Profilo
Il signor David G. Forster è un responsabile della conformità presso WIRB-Copernicus Group, Inc., un responsabile della conformità presso WCG Clinical, Inc. e un responsabile della conformità presso Western Institutional Review Board, Inc.
Posizioni attive di David Forster
| Società | Posizione | Inizio |
|---|---|---|
| WCG CLINICAL, INC. | Compliance Officer | - |
WCG IRB, Inc.
 WCG IRB, Inc. Miscellaneous Commercial ServicesCommercial Services WCG IRB, Inc. provides clinical research, review, and individual investigation services. It is a provider of review services to academic centers, hospitals, networks, and in-house biotech research institutions, as well as for individual investigators. The company offers regulatory skills for the development of research protocols and documentation. Western Institutional Review Board was founded in 1968 by Angela J. Bowen and is headquartered in Olympia, WA. | Compliance Officer | 04/09/2012 |
Formazione di David Forster
| University of Washington | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
WCG IRB, Inc.
WCG IRB, Inc. Miscellaneous Commercial ServicesCommercial Services WCG IRB, Inc. provides clinical research, review, and individual investigation services. It is a provider of review services to academic centers, hospitals, networks, and in-house biotech research institutions, as well as for individual investigators. The company offers regulatory skills for the development of research protocols and documentation. Western Institutional Review Board was founded in 1968 by Angela J. Bowen and is headquartered in Olympia, WA. | Commercial Services |
WCG Clinical, Inc.
 WCG Clinical, Inc. BiotechnologyHealth Technology WCG Clinical, Inc. provides clinical trial solutions, which focus on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance. It transformational solutions enable biopharmaceutical companies, contract research organizations, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human protection. The company was founded in 2012 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- David Forster
